Suppr超能文献

一例伴有E1143G聚合酶γ突变的药物性帕金森综合征和迟发性静坐不能——无辜旁观者还是罪魁祸首?

A case of drug-induced parkinsonism and tardive akathisia with e1143g polymerase γ mutation-innocent bystander or a culprit?

作者信息

Idiculla Pretty Sara, Hussain Syed Taimour, Siddiqui Junaid Habib

机构信息

University of Missouri Health Care, 1 Hospital Drive, Columbia, Missouri-65212, United States.

United Medical and Dental College, Karachi, Pakistan.

出版信息

J Clin Transl Res. 2021 May 14;7(3):297-301. eCollection 2021 Jun 26.

Abstract

BACKGROUND AND AIM

Polymerase γ (POLG) is a protein that plays a pivotal role in the replication of the mitochondrial genome. POLG-related disorders constitute a sequence of overlying phenotypes that can present from early infancy to late adulthood. Parkinsonism is the most common movement disorder associated with POLG mutation. We also summarize all reported cases of POLG-related Parkinsonism, along with a literature review.

CASE DESCRIPTION

We present the case of an 80-year-old male presented with complaints of episodic confusion, tremors, and restlessness. He has been on risperidone for psychosis. A normal DaT scan ruled out Parkinson's disease, and molecular analysis for POLG was positive (E1143G). He was diagnosed with drug-induced Parkinsonism and tardive akathisia with an incidental POLG mutation.

CONCLUSIONS

A literature search revealed 55 cases of "POLG-related Parkinsonism" that met our criteria. These mutations can clinically affect multiple organ systems. Parkinsonism is the most common movement disorder reported in association with POLG mutations. We conducted a molecular analysis in our patient due to his Parkinsonism and recurrent episodes of encephalopathy. E1143G mutation found in our case was coincidental and reported a non-pathogenic or benign variant in literature.

RELEVANCE FOR PATIENTS

E1143G is a non-pathogenic variant and multiple studies have shown that its co-occurrence with other POLG mutations can aggravate disease occurrence and severity. Literature findings and the experience from our own case indicate that the pathogenicity of E1143G is debatable, and future studies involving this particular variant may help understand its pathological consequences.

摘要

背景与目的

聚合酶γ(POLG)是一种在线粒体基因组复制中起关键作用的蛋白质。POLG相关疾病构成了一系列从婴儿早期到成年晚期都可能出现的重叠表型。帕金森症是与POLG突变相关的最常见运动障碍。我们还总结了所有已报道的POLG相关帕金森症病例,并进行文献综述。

病例描述

我们报告一例80岁男性,主诉有发作性意识模糊、震颤和坐立不安。他因精神病服用利培酮。正常的多巴胺转运体(DaT)扫描排除了帕金森病,POLG分子分析呈阳性(E1143G)。他被诊断为药物性帕金森症和迟发性静坐不能,伴有偶然发现的POLG突变。

结论

文献检索发现55例符合我们标准的“POLG相关帕金森症”病例。这些突变在临床上可影响多个器官系统。帕金森症是与POLG突变相关报道中最常见的运动障碍。由于我们的患者患有帕金森症且有反复发作的脑病,我们对其进行了分子分析。我们病例中发现的E1143G突变是偶然的,文献报道其为非致病性或良性变异。

对患者的意义

E1143G是一种非致病性变异,多项研究表明它与其他POLG突变同时出现会加重疾病发生和严重程度。文献研究结果和我们自身病例的经验表明,E1143G的致病性存在争议,未来涉及这一特定变异的研究可能有助于了解其病理后果。

相似文献

3
Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders.
Hum Mol Genet. 2006 Dec 1;15(23):3473-83. doi: 10.1093/hmg/ddl424. Epub 2006 Nov 6.
4
[Hereditary Parkinson’s disease as a new clinical manifestation of the damaged POLG gene].
Orv Hetil. 2020 May 1;161(20):821-828. doi: 10.1556/650.2020.31724.
5
Novel mutation in a patient with early-onset parkinsonism, progressive external ophthalmoplegia and optic atrophy.
Int J Neurosci. 2020 Apr;130(4):319-321. doi: 10.1080/00207454.2019.1681422. Epub 2019 Nov 7.
6
Changing faces of mitochondrial disease: autosomal recessive disease mimicking myasthenia gravis and progressive supranuclear palsy.
BMJ Neurol Open. 2022 Dec 8;4(2):e000352. doi: 10.1136/bmjno-2022-000352. eCollection 2022.
7
POLG R964C and GBA L444P mutations in familial Parkinson's disease: Case report and literature review.
Brain Behav. 2019 May;9(5):e01281. doi: 10.1002/brb3.1281. Epub 2019 Apr 2.
8
Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database.
BBA Clin. 2017 Apr 18;7:147-156. doi: 10.1016/j.bbacli.2017.04.001. eCollection 2017 Jun.
9
Clinico-pathological and Molecular Spectrum of Mitochondrial Polymerase γ Mutations in a Cohort from India.
J Mol Neurosci. 2021 Nov;71(11):2219-2228. doi: 10.1007/s12031-020-01765-8. Epub 2021 Jan 19.
10
Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is Present.
J Mov Disord. 2021 May;14(2):157-160. doi: 10.14802/jmd.20159. Epub 2021 May 26.

本文引用的文献

2
Novel mutation in a patient with early-onset parkinsonism, progressive external ophthalmoplegia and optic atrophy.
Int J Neurosci. 2020 Apr;130(4):319-321. doi: 10.1080/00207454.2019.1681422. Epub 2019 Nov 7.
3
POLG R964C and GBA L444P mutations in familial Parkinson's disease: Case report and literature review.
Brain Behav. 2019 May;9(5):e01281. doi: 10.1002/brb3.1281. Epub 2019 Apr 2.
4
Late-onset presentation of POLG1-associated mitochondrial disease.
BMJ Case Rep. 2019 Mar 31;12(3):e228482. doi: 10.1136/bcr-2018-228482.
5
POLG-related disorders and their neurological manifestations.
Nat Rev Neurol. 2019 Jan;15(1):40-52. doi: 10.1038/s41582-018-0101-0.
6
Movement disorders in genetically confirmed mitochondrial disease and the putative role of the cerebellum.
Mov Disord. 2018 Jan;33(1):146-155. doi: 10.1002/mds.27174. Epub 2017 Sep 13.
7
Clinical Reasoning: A 58-year-old man with progressive ptosis and walking difficulty.
Neurology. 2017 Jul 4;89(1):e1-e5. doi: 10.1212/WNL.0000000000004064.
8
Pathogenicity in POLG syndromes: DNA polymerase gamma pathogenicity prediction server and database.
BBA Clin. 2017 Apr 18;7:147-156. doi: 10.1016/j.bbacli.2017.04.001. eCollection 2017 Jun.
9
Juvenile onset Parkinsonism with "pure nigral" degeneration and POLG1 mutation.
Parkinsonism Relat Disord. 2016 Sep;30:83-5. doi: 10.1016/j.parkreldis.2016.06.013. Epub 2016 Jun 21.
10
Early-onset parkinsonism due to compound heterozygous POLG mutations.
Parkinsonism Relat Disord. 2016 Aug;29:135-7. doi: 10.1016/j.parkreldis.2016.04.020. Epub 2016 Apr 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验